title: Intravitreal aflibercept treatment of retinal angiomatous proliferation: a pilot study and short-term efficacy.
authors.affiliation: Ophthalmology Department, Leicester Royal Infirmary, Leicester, UK, konstantinos.tsaousis@gmail.com.
authors.forename: Konstantinos T
authors.initials: KT
authors.lastname: Tsaousis
authors.forename: Vasileios E
authors.initials: VE
authors.lastname: Konidaris
authors.forename: Somnath
authors.initials: S
authors.lastname: Banerjee
authors.forename: Theodoros
authors.initials: T
authors.lastname: Empeslidis
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D010865:Pilot Projects; D011446:Prospective Studies; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012160:Retina / Q000187:drug effects / Q000473:pathology; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology; D057135:Wet Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor